Literature DB >> 8076807

Expression of mRNA encoding IFN alpha in macrophages stimulated with Lactobacillus gasseri.

H Kitazawa1, Y Tomioka, K Matsumura, H Aso, M Mizugaki, T Itoh, T Yamaguchi.   

Abstract

The ability of Lactobacillus gasseri, a dairy lactic acid bacterium, to induce interferon (IFN) was investigated in murine macrophage cultures. IFN alpha was substantially induced by some strains of L. gasseri and the titers were the highest at a concentration of 100 micrograms ml-1 of L. gasseri DSM20243T. The expression of mRNA encoding IFN alpha was detected in spleen-macrophages (SP-M phi) and Peyer's patch-adherent cells stimulated with L. gasseri DSM20243T. Actinomycin D and cycloheximide added to SP-M phi cultures showed that the mRNA was synthesized by 0.5 h, and that IFN alpha was produced within 3 to 6 h after the stimulation with L. gasseri DSM20243T. The results support the notion that dairy products containing L. gasseri can be 'physiologically functional foods'.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8076807     DOI: 10.1111/j.1574-6968.1994.tb07052.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  6 in total

1.  Cytokine profile and induction of T helper type 17 and regulatory T cells by human peripheral mononuclear cells after microbial exposure.

Authors:  O N Donkor; M Ravikumar; O Proudfoot; S L Day; V Apostolopoulos; G Paukovics; T Vasiljevic; S L Nutt; H Gill
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

2.  Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria.

Authors:  M Miettinen; J Vuopio-Varkila; K Varkila
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells.

Authors:  Kenta Jounai; Kumiko Ikado; Tetsu Sugimura; Yasuhisa Ano; Jonathan Braun; Daisuke Fujiwara
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

Review 4.  The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19.

Authors:  Amin N Olaimat; Iman Aolymat; Murad Al-Holy; Mutamed Ayyash; Mahmoud Abu Ghoush; Anas A Al-Nabulsi; Tareq Osaili; Vasso Apostolopoulos; Shao-Quan Liu; Nagendra P Shah
Journal:  NPJ Sci Food       Date:  2020-10-05

Review 5.  Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Hamedah Sabbah Alenezi; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-06-18       Impact factor: 4.052

6.  Beneficial bacteria activate type-I interferon production via the intracellular cytosolic sensors STING and MAVS.

Authors:  Jorge Gutierrez-Merino; Beatriz Isla; Theo Combes; Fernando Martinez-Estrada; Carlos Maluquer De Motes
Journal:  Gut Microbes       Date:  2020-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.